Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Why Iovance Biotherapeutics Stock Was Climbing Today (Fool) +++ IOVANCE Aktie -3,21%

CHEMOURS Aktie

 >CHEMOURS Aktienkurs 
12.91 EUR    +0.7%    (Tradegate)
Ask: 13 EUR / 769 Stück
Bid: 12.8 EUR / 781 Stück
Tagesumsatz: 6260 Stück
Realtime Kurs von 8 bis 22 Uhr!
CHEMOURS Aktie über LYNX handeln
>CHEMOURS Performance
1 Woche: +23,0%
1 Monat: +10,2%
3 Monate: +30,0%
6 Monate: -22,0%
1 Jahr: -22,8%
laufendes Jahr: -20,1%
>CHEMOURS Aktie
Name:  CHEMOURS CO. DL-,01
Land:  USA
Sektor:  Chemie
ISIN/ Wkn:  US1638511089 / A14RPH
Symbol/ Ticker:  2CU (Frankfurt) / CC (NYSE)
Kürzel:  FRA:2CU, ETR:2CU, 2CU:GR, NYSE:CC
Index:  -
Webseite:  https://www.chemours.com/
Profil:  Chemours Co. is a leading global provider of perfo..
>Volltext..
Marktkapitalisierung:  1916.78 Mio. EUR
Unternehmenswert:  5229.26 Mio. EUR
Umsatz:  5034.37 Mio. EUR
EBITDA:  631.22 Mio. EUR
Nettogewinn:  -359.72 Mio. EUR
Gewinn je Aktie:  -2.4 EUR
Schulden:  3774.49 Mio. EUR
Liquide Mittel:  429.95 Mio. EUR
Operativer Cashflow:  220.97 Mio. EUR
Bargeldquote:  0.27
Umsatzwachstum:  -6.82%
Gewinnwachstum:  -429.22%
Dividende je Aktie:  0.54 EUR
Dividendenrendite:  5.73%
Dividendenschätzung:  2.34%
Div. Historie:  16.05.25 - 0.07811999€
28.02.25 - 0.2305€
>weitere anzeigen...
Insiderhandel:  1 Insider kaufte innerhalb der letzten 30 Tage Aktien im Wert von 49.060 USD.
Suchwörter:  CHEMOURS
Letzte Datenerhebung:  19.08.25
>CHEMOURS Kennzahlen
Aktien/ Unternehmen:
Aktien: 149.7 Mio. St.
Frei handelbar: 99.25%
Rückkaufquote: -0.04%
Mitarbeiter: 6000
Umsatz/Mitarb.: 0.83 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 5.84%
Bewertung:
KGV: -
KGV lG: 11.36
KUV: 0.38
KBV: 9.37
PEG-Ratio: -
EV/EBITDA: 8.28
Rentabilität:
Bruttomarge: 18.32%
Gewinnmarge: -7.15%
Operative Marge: 6.84%
Managementeffizenz:
Gesamtkaprendite: -5.7%
Eigenkaprendite: -87.5%
>CHEMOURS Peer Group

Es sind 93 Aktien bekannt.
 
14.08.25 - 00:48
Chemours surges to five-month high after cooling fluid qualifies with Samsung SSDs (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
13.08.25 - 00:01
Insiderhandel: President & CEO kauft Aktien von Chemours Co im Wert von 49060 USD (Insiderkauf)
 
Dignam, Denise - Vorstand - Tag der Transaktion: 2025-08-08...
12.08.25 - 17:30
Chemours Q2 Earnings & Revenues Beat Estimates on Higher Volumes (Zacks)
 
CC posts Q2 earnings and sales beat driven by volume and pricing gains, but issues softer sequential guidance....
06.08.25 - 22:24
Chemours (CC) Q2 EPS Jumps 53% (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
06.08.25 - 11:39
Chemours declares $0.0875 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.08.25 - 02:30
Chemours (CC) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
 
The headline numbers for Chemours (CC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....
06.08.25 - 01:45
Chemours (CC) Tops Q2 Earnings and Revenue Estimates (Zacks)
 
Chemours (CC) delivered earnings and revenue surprises of +26.09% and +2.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...
05.08.25 - 23:24
Chemours stock edges higher as company beats quarterly estimates (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.25 - 23:06
Chemours Non-GAAP EPS of $0.58 beats by $0.12, revenue of $1.6B beats by $30M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.25 - 22:57
The Chemours Company Reports Second Quarter 2025 Results (Business Wire)
 
WILMINGTON, Del.--(BUSINESS WIRE)--$CC--The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and Advanced Performance Materials (“APM”), today announced its financial results for the second quarter 2025. Key Second Quarter 2025 Results & Highlights1 Net Sales of $1.6 billion, a 4% increase compared to the corresponding prior-year quarter, with TSS achieving year-over-year growth of 65% in Opteon™ Refrigerants Net Loss attributable to Chemours of $381 million, or $2.54 per diluted share, compared with Net Income attributable to Chemours of $60 million, or $0.39 per diluted share, in the corresponding prior-year quarter Adjusted Net Income2 of $87 million, or $0.58 per diluted share, compared to $58 million, or $0.38 per diluted share, in the corresponding prior-year quarter Adjusted EBITDA2,3 of $253 million compared to $207 million in the corres...
04.08.25 - 23:21
Chemours Q2 2025 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
04.08.25 - 14:21
Chemours, DuPont, Corteva settle New Jersey PFAS claims for $875 million (Reuters EN)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
04.08.25 - 13:21
Chemours, DuPont, Corteva settle New Jersey environmental claims including PFAS for $875M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
29.07.25 - 22:33
Chemours Announces Dates for Second Quarter 2025 Earnings Release and Webcast Conference Call (Business Wire)
 
WILMINGTON, Del.--(BUSINESS WIRE)--$CC--The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) today announced that the Company expects to issue its second quarter 2025 financial results after market on Tuesday, August 5, 2025. The Company expects to hold its conference call to discuss its second quarter 2025 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, August 6, 2025. The call is open to the public and can be accessed via the webcast information below. Prior to the Company's conference call, management will post additional prepared financial remarks in the "Events and Presentations" section of the Investor Relations section of Chemours' website at investors.chemours.com. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE: CC) is a global leader in providing industri...
08.07.25 - 18:36
Stocks making the biggest moves midday: Hershey, Chemours, Fair Isaac, Sunrun & more (CNBC)
 
These are the stocks posting the largest moves midday....
08.07.25 - 18:16
Chemours surges to highest since March as EPA pulls plan to rewrite asbestos phaseout rule (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.07.25 - 15:15
UBS Finds "Chilling Opportunity" In Data Center Cooling  (ZeroHedge)
 
UBS Finds "Chilling Opportunity" In Data Center Cooling  As artificial intelligence chips become more powerful and energy-intensive, legacy air-based cooling systems are fast approaching obsolescence. Chemours is addressing this gap with its next-generation 2-phase liquid cooling technologies, which UBS describes as "purpose-built for more demanding applications in data centers." With thermal loads projected to exceed 200 to 1,000 kW per rack by the end of the decade, advanced cooling is no longer optional. UBS, calling it a "chilling opportunity," sees Chemours well-positioned to lead this transition. A team of analysts led by Joshua Spector stated that Chemours is commercializing two proprietary 2-phase coolant solutions — Opteon SF33 for direct-to-chip cooling and Opteon 2P50 for immersion cooling — aimed at cooling next-generation AI data centers operating at high kW per rack.  What is Chemours doing with data centers? Spector noted: Chemours has devel...
23.06.25 - 15:00
CC Sees Gains From Opteon Growth in Q2, Navigates Disruptions in TT (Zacks)
 
Chemours' second-quarter sales are expected to be at the high end of its guidance as TT disruptions get offset by Opteon demand boosts....
18.06.25 - 21:45
Chemours foresees strong Q2 sales increase on strong refrigerant demand (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
12.06.25 - 22:33
Chemours Appoints Matthew Conti as Chief Human Resources Officer (Business Wire)
 
Seasoned HR executive supports Chemours' Pathway to Thrive strategyWILMINGTON, Del.--(BUSINESS WIRE)--$CC--The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today announced the appointment of Matthew Conti as Chief Human Resources Officer (CHRO), effective June 2. His appointment follows an extensive external search to identify a leader who will drive Chemours' people and culture strategy. In this role, Conti will lead Chemours' global human resources organization, overseeing talent strategy, organizational development, employee engagement, and culture initiatives. He will play a pivotal role in advancing the company's Pathway to Thrive strategy by aligning human capital priorities with business objectives and fostering a high-performing culture. “Matthew's appointment comes at a critical time as we continue to evolve our culture and capa...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Am Anfang war die Kraft. - Paula Modersohn-Becker
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!